Barclays PLC Bristol Myers Squibb CO Transaction History

Barclays PLC

$327 Billion
Q2 2024

A detailed history of Barclays PLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Barclays PLC holds 7,136,134 shares of BMY stock, worth $380 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

7,136,134

Previous 6,096,393 17.06%

Holding current value

$380 Million

Previous $331 Million 10.36%

% of portfolio

0.09%

Previous 0.11%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $41.8 Million - $55.1 Million	1,039,741 Added 17.06%	7,136,134 $296 Million
Q1 2024 May 15, 2024	SELL	$47.98 - $54.4 $35.8 Million - $40.6 Million	-746,516 Reduced 10.91%	6,096,393 $331 Million
Q4 2023 Feb 15, 2024	BUY	$48.48 - $57.85 $66.6 Million - $79.5 Million	1,374,120 Added 25.13%	6,842,909 $351 Million
Q3 2023 Nov 07, 2023	SELL	$57.89 - $64.73 $39.9 Million - $44.6 Million	-688,768 Reduced 11.19%	5,468,789 $317 Million
Q2 2023 Aug 03, 2023	BUY	$63.71 - $70.74 $134 Million - $148 Million	2,098,933 Added 51.72%	6,157,557 $394 Million
Q1 2023 May 04, 2023	SELL	$65.71 - $74.53 $35.8 Million - $40.6 Million	-545,302 Reduced 11.84%	4,058,624 $281 Million
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $45.1 Million - $53.4 Million	658,936 Added 16.7%	4,603,926 $331 Million
Q3 2022 Nov 03, 2022	BUY	$0.13 - $76.84 $15,987 - $9.45 Million	122,980 Added 3.22%	3,944,990 $280 Million
Q2 2022 Aug 12, 2022	SELL	$72.62 - $79.98 $86.9 Million - $95.7 Million	-1,196,819 Reduced 23.85%	3,822,010 $294 Million
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $138 Million - $166 Million	-2,245,605 Reduced 30.91%	5,018,829 $367 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $13.7 Million - $15.9 Million	254,904 Added 3.64%	7,264,434 $453 Million
Q3 2021 Nov 09, 2021	BUY	$59.17 - $69.31 $139 Million - $162 Million	2,344,458 Added 50.26%	7,009,530 $415 Million
Q2 2021 Aug 13, 2021	BUY	$61.91 - $67.42 $41 Million - $44.6 Million	661,754 Added 16.53%	4,665,072 $312 Million
Q1 2021 May 13, 2021	BUY	$59.34 - $66.74 $50.8 Million - $57.1 Million	856,053 Added 27.2%	4,003,318 $253 Million
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $12.1 Million - $13.8 Million	210,271 Added 7.16%	3,147,265 $195 Million
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $19.5 Million - $21.6 Million	338,693 Added 13.04%	2,936,994 $177 Million
Q2 2020 Aug 12, 2020	BUY	$54.82 - $64.09 $13.3 Million - $15.5 Million	241,711 Added 10.26%	2,598,301 $153 Million
Q1 2020 May 13, 2020	SELL	$46.4 - $67.43 $125 Million - $181 Million	-2,690,542 Reduced 53.31%	2,356,590 $131 Million
Q4 2019 Feb 10, 2020	BUY	$49.21 - $64.19 $73.9 Million - $96.4 Million	1,501,786 Added 42.36%	5,047,132 $324 Million
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $9.09 Million - $10.8 Million	-212,568 Reduced 5.66%	3,545,346 $180 Million
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $3.1 Million - $3.42 Million	-69,378 Reduced 1.81%	3,757,914 $170 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $60.4 Million - $72 Million	1,338,565 Added 53.79%	3,827,292 $183 Million
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $26.6 Million - $34.4 Million	-544,598 Reduced 17.95%	2,488,727 $129 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $190 Million - $214 Million	-3,445,486 Reduced 53.18%	3,033,325 $188 Million
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $128 Million - $160 Million	2,538,241 Added 64.41%	6,478,811 $359 Million
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $76.2 Million - $87.7 Million	1,271,252 Added 47.62%	3,940,570 $249 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $46.6 Million - $50.8 Million	777,696 Added 41.11%	2,669,318 $164 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $104 Million - $121 Million	1,891,622	1,891,622 $121 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account